Peptide stacks · Growth hormone

Hexarelin and CJC-1295 stack: what’s in it and the evidence

Checked against our library and study pagesPublished by PepVault

The hexarelin and CJC-1295 stack is two compounds run side by side, each from its own vial or form: hexarelin and CJC-1295 no DAC. The library records hexarelin at 100–200 mcg and CJC-1295 no DAC at 100–200 mcg per dose as reference ranges.

This page describes what the crowd runs and what a vial holds. It recommends no stack and names no seller.

What’s in the hexarelin and CJC-1295 stack

The two parts of the hexarelin and CJC-1295 stack
PartReference rangeFiled underEvidence (library)
Hexarelin100–200 mcgStrong GH pulse, Short cycles onlyModerate
CJC-1295 no DAC100–200 mcgPulsatile GH, Ipamorelin synergy, RecoveryModerate

The library’s reference range per dose, part by part

  • Hexarelin100–200 mcg

  • CJC-1295 no DAC100–200 mcg

Each bar runs from the low to the high end of what the library records for each part of the hexarelin and CJC-1295 stack, on one scale.

Hexarelin

Hexarelin is one of the two parts of the hexarelin and CJC-1295 stack. One of the most powerful GH secretagogues, with a catch: the response fades.

CJC-1295 no DAC

CJC-1295 no DAC is one of the two parts of the hexarelin and CJC-1295 stack. The shorter-acting version of CJC-1295, meant to give sharp, pulse-like GH release.

A smiling man in a navy t-shirt at his garage gym, a towel over his shoulder, holding his phone

PepVault for iPhone

Track your stack in PepVault

Log every compound in a stack, each on its own schedule, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Has the hexarelin and CJC-1295 stack been studied as a combination?

None of our 436 study pages tested hexarelin and CJC-1295 no DAC together, so the hexarelin and CJC-1295 stack rests on studies of its parts and on community reports.

The studies of the parts, one by one: 5 study pages on hexarelin (3 in people) and 0 study pages on CJC-1295 no DAC (0 in people).

Our study pages on each part of the hexarelin and CJC-1295 stack
PartStudy pagesIn peopleStrongest study page
Hexarelin53Hexarelin cut deep sleep and raised GH, ACTH, cortisol, prolactin (clinical trial, 2004)
CJC-1295 no DAC00None yet

What people commonly report on the hexarelin and CJC-1295 stack

The library holds no report of what people notice on the hexarelin and CJC-1295 stack as a pair. What it records for each part on its own:

  • Hexarelin: a strong effect at first, flushing or a head rush after injecting, and water retention with some hunger (less than GHRP-6).
  • CJC-1295 no DAC: a flush or head rush within minutes of injecting, deeper sleep and vivid dreams early on, and mild water retention over the weeks.

These are reports from people who run it, collected in the library, not results from a trial and not a promise of what any one person will notice.

Why these are combined

“Hexarelin + CJC-1295 is potent but desensitizes fast”, the library’s note on the pair (community report)

Hexarelin is the highest-efficacy GH secretagogue, and pairing it with CJC-1295's raised baseline produces a strong release — but Hexarelin desensitizes the GH receptor with continuous use faster than Ipamorelin does. If selectivity and sustainability matter more than peak output, Ipamorelin is the gentler partner for CJC.

How the parts of the hexarelin and CJC-1295 stack are mixed and taken

The hexarelin and CJC-1295 stack isn’t one pre-mixed vial in the library: each part has its own route and schedule, as its entry records them.

How each part of the hexarelin and CJC-1295 stack is taken, from its library entry
PartRouteHow oftenOur vial pages
HexarelinSubQ injection2–3x daily5 mg vial
CJC-1295 no DACSubQ injection2–3x daily5 mg vial

Our vial pages work out the mix for each part’s own vial, size by size:

Compared with running the parts apart

The library’s notes on the hexarelin and CJC-1295 stack don’t compare it with running either part on its own.

Safety notes

The library holds no combination safety note on the hexarelin and CJC-1295 stack, so each part’s own notes apply, on its compound page.

These are reference notes from published research and reported use, not advice for a person: discuss your own situation with your clinician.

Questions people ask

What is in the hexarelin and CJC-1295 stack?

The hexarelin and CJC-1295 stack is two compounds run side by side, each from its own vial or form: hexarelin and CJC-1295 no DAC. The library records hexarelin at 100–200 mcg and CJC-1295 no DAC at 100–200 mcg per dose as reference ranges.

Has the hexarelin and CJC-1295 stack been studied together?

Not as a combination in any of our study pages: the hexarelin and CJC-1295 stack rests on studies of its parts and on community reports.

Do the parts of the hexarelin and CJC-1295 stack come in one vial?

No: in the library each part of the hexarelin and CJC-1295 stack is its own compound with its own route and schedule (hexarelin by SubQ injection and CJC-1295 no DAC by SubQ injection).

What does each part of the hexarelin and CJC-1295 stack do?

Hexarelin: One of the most powerful GH secretagogues, with a catch: the response fades. CJC-1295 no DAC: The shorter-acting version of CJC-1295, meant to give sharp, pulse-like GH release.

More on these compounds

Track it in the app

PepVault for iPhone

Track your stack in PepVault

Log every compound in a stack, each on its own schedule, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo